With more than 10+ years of research experience, 14+ publications in Q1 journals, my research portfolio spans interdisciplinary approaches to molecular biology, translational medicine, and computational biology with significant contributions to cancer biology, neurological disorders, and metabolic diseases. Currently serving as Project Scientist-II at ICMR-National Institute of Child Health & Development Research, New Delhi, I lead translational research on acute lymphoblastic and myeloid leukemias by integrating computational and experimental approaches. My innovative work combines next-generation sequencing with protein-protein interaction network analysis in Cytoscape to identify novel diagnostic and therapeutic targets, demonstrating my expertise in CRISPR knock-down assays, ligand-binding studies, and molecular docking with AutoDock Vina. My research achievements include securing internal seed funding for FDA-approved kinase inhibitor trials in pediatric AML and establishing biomarker discovery pipelines using LC-MS/MS profiling and flow-cytometric immunophenotyping. During my Ph.D. research at Regional Plant Resource Centre, Bhubaneswar, I focused on developing and validating bioassays for phytochemical analysis and isolation of bioactive plant constituents, with notable success in demonstrating neuroprotective and antidiabetic activities of Hydrolea zeylanica in rodent models of diabetic encephalopathy and hyperglycemia.
ICMR National Institute of Child Health Research (ICMR-NICHR)
New Delhi, India